N/A N=2,595 Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP
Sudden Cardiac Death
Primary: All-Cause Shock — 129; 178 Participants — p=0.005
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=30 Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy
Kidney Stone · Ureteral Calculi · Nephrolithiasis
Primary: Pain on 11-point Visual Analog Score Scale (VAS) — 3.52; 3.42; 4.44; 4.02 score on a scale — p=0.93
Phase 1 N=39 A Social Network AOD Intervention for Homeless Youth Transitioning to Housing
Substance Use
Primary: Number of Days Cannabis Used — 23.7; 7.36 days
N/A N=7 Episodic Future Thinking and Weight-Loss
Overweight and Obesity
Primary: Change in BMI for Parent Participants From Baseline at Weeks 8, 11 and 15 — 32.7; 36.9; -1.3; -1.9 kg/m^2 — p=<0.01
Phase 1 N=1 Testing Nivolumab in Combination With Decitabine and Venetoclax in Patients With Newly Diagnosed TP53 Gene Mutated Acute Myeloid Leukemia
Acute Myeloid Leukemia
Primary: Incidence of Adverse Events — 1; 1; 1; 1 participants
N/A N=57 Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video
Breast Cancer
Primary: Rate of Genetic Counseling and Testing Uptake. — 18; 15; 7; 12 Participants
Phase 2 N=200 DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia
Staphylococcal Bacteraemia
Primary: Desirability of Outcome Ranking (DOOR) — 49; 49; 34; 37 Participants
Phase 3 N=441 Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers
Stage III Distal Bile Duct Cancer AJCC v8 · Stage III Gallbladder Cancer AJCC v8 · Stage III Intrahepatic Cholangiocarcinoma AJCC v8
Primary: Overall Survival (OS) — 14.0; 13.6 months — p=0.41
N/A N=27 Task Switching Behavior Between Target Templates During Visual Search in Healthy Adults
Healthy
Primary: Button Press Reaction Time — 1.68; 1.69; 1.76; 1.77 Seconds — p=<.05
N/A N=31 Water Content in E-Liquids
Nicotine E-Cigarette Use
Primary: Irritation/Harshness — 1.04; 1.07; 1.03; 1.01 units on a scale — p=0.0014
Phase 3 N=292 A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies
Spinal Muscular Atrophy
Primary: Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) — 13; 24; 65; 12 Participants
N/A N=12 Socket Cooling Effectiveness Take Home Study
Amputation · Amputation; Traumatic, Leg, Lower · Amputation Stump
Primary: Residual Limb Temperature — -2.3; 1.9 Avg Temp Diff from Baseline (Degrees C)
Phase 4 N=21 A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery
Pediatric Cardiac Surgery · Complication of Extracorporeal Circulation
Primary: Inflammatory Markers/Cytokines — 1.5; 2.1; 1.6; 2.2 pg/dl
N/A N=23 Using Open Contest and Neuro-influence Experiment to Develop and Evaluate PrEP Promotion Messages for High Risk Men
HIV/AIDS
Primary: Change of Willingness to Take PrEP — 0; 0.5 units on a scale
N/A N=15 Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis
Malignant Solid Neoplasm
Primary: Contrast to Noise Ratio — 3.2 Ratio — p=< 0.05